Literature DB >> 8114781

Congenital myopathies.

J B Bodensteiner1.   

Abstract

Several dozen congenital myopathies are defined by clinical and morphological criteria. The application of the current generation of scientific techniques including immunohistochemistry and molecular genetics has resulted in the expansion of our knowledge and understanding of the well-established conditions including central core myopathy and centronuclear/myotubular myopathy and allowed greater understanding of the interrelationships of some of the less common or less well-established conditions. In the near future molecular genetics may allow the identification of the specific gene defect in many of these diseases. This article reviews the major congenital myopathies and presents some of the information gained by application of new technology to these conditions.

Entities:  

Mesh:

Year:  1994        PMID: 8114781     DOI: 10.1002/mus.880170202

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Comparison of clinical characteristics between congenital fiber type disproportion myopathy and congenital myopathy with type 1 fiber predominance.

Authors:  Sang-Jun Na; Woo-Kyung Kim; Tai-Seung Kim; Seong-Woong Kang; Eun-Young Lee; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

Review 2.  Recent advances in muscular dystrophies and myopathies.

Authors:  J R Anderson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

3.  Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases.

Authors:  Katarzyna A Piróg; Yoshihisa Katakura; Aleksandr Mironov; Michael D Briggs
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia.

Authors:  Katarzyna A Piróg; Oihane Jaka; Yoshihisa Katakura; Roger S Meadows; Karl E Kadler; Raymond P Boot-Handford; Michael D Briggs
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.